Files

Download

Download Full Text (1022 KB)

Description

Goal: To better understand drug resistance and sensitivity in patients with late stage (Stage III & IV) cancers that are receiving standard of care molecularly targeted therapies through next generation sequencing (NGS) of biopsy and blood samples collected longitudinally (diagnosis-- treatment--progression).

Publication Date

2021

Publisher

Maine Medical Center

City

Portland, Maine

Keywords

Cancer Moonshot BioBank (CMB), Maine Cancer Genetics/Genomics Education Core (ME-CGEC), Cancer, Genomic Testing, Study Plan

Disciplines

Oncology

The NCI/NIH Cancer Moonshot BioBank (CMB) and the Maine Cancer Genetics/Genomics Education Core (ME-CGEC) Collaborate to Improve Cancer Care in Maine

Included in

Oncology Commons

Share

COinS